Gilead Sciences (NASDAQ:GILD) is on its way to becoming the second-largest pharmaceutical company in the US, perhaps even doing so this year. Gilead's growth has been nothing short of astounding, as it has transitioned in the past two years from a solid, medium-sized pharmaceutical company to one of the largest pharma companies in the world. Gilead is now a larger company ($160 B market cap) than many familiar pharma names. The only way it can sustain growth is through acquisitions.
Oppenheimer raised their price target on shares of Lannett Company from $49.00 to $52.00 in a research note on Tuesday, July 15th. They now have an “outperform” rating on the stock. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $47.00.
Ukraine said its troops attacked and partially destroyed a column of armed vehicles that had crossed the border from Russian territory, while Russia said it was concerned about an attack on another convoy carrying aid.
Ukrainian government troops engaged the vehicles that had arrived overnight through a rebel-held section of the border, Andriy Lysenko, a spokesman for the country’s military, told reporters in Kiev today. Ukrainian soldiers continue to come under shelling, including rounds fired from Russia, he said.
The government in Kiev has for months said that separatist rebels in its easternmost regions are receiving support from Russia, which backs them with artillery fire. Russia has repeatedly denied any involvement in the Ukrainian unrest.
Take a victory lap. You were the most bullish poster on the board.
I was just going to post. ARWR has a very promising hep-B drug in phase 2. Results to date are very favorable. Up 9% today.
ARWR would be an ideal candidate for takeover by a bigger company looking to expand itd hepatitis drug portfolio. (hint, hint)
I sold 40% of my JAZZ stock. If insiders are cutting back, so am I.
Check out ARWR, up 8% on hepatitis drug results. Possible buyout candidate if Giliad wants to expand its hepatitis drug portfolio.
Less than two years after four Americans got massacred in a terrorist attack on the U.S. Special Mission in Benghazi, Libya the Obama administration is disregarding congressional opposition to lift a decades-old ban on Libyans attending flight schools and training as nuclear scientists in the United States.
The ban was implemented in 1983 after a wave of terrorist incidents involving Libyans. The African nation continues to be a hotbed of terrorism and in fact, the U.S. Embassy in Tripoli was recently evacuated because violence between rival militias has created a deadly environment. Many other foreign governments have also shut down their embassies in Libya because the violence has spread throughout the entire country.
Nevertheless, President Obama has discounted congressional opposition to let Libyans train as pilots, airplane mechanics and nuclear scientists in the United States. Perhaps the commander-in-chief has somehow forgotten that many of the 9/11 hijackers—mostly Saudi nationals—received their training in American flights schools because our government allowed it. Have we not learned that it’s a really bad idea to help our enemies obtain skills that could later be used to attack us?
Official word of this senseless change comes via a final regulation approved by the Office of Management and Budget (OMB). It lifts the longtime prohibition on Libyans coming to the U.S. to attend flight school, work in aviation maintenance or flight operations or to study or train in nuclear science. The Obama administration claims that the ban is no longer necessary because the “United States Government and the Government of Libya have normalized their relationship and most of the restrictions and sanctions imposed by the United States and the United Nations toward Libya have been lifted.”
The move comes just a few months after a congressional hearing addressed what was then the administration’s proposal to overturn the 30-year ban.
You guys are confusing operating profits (revenues) and earnings.
AMZN has high revenues but reinvests it all back into the business and reports negative net earnings.
A P/E Ratio is meaningless unless you also consider growth. You should focus on the PEG ratio which indicates VIPS is still not expensive.
VIPS PEG ratio is 0.97.
In terms of Wall Street expectations, a lot of investors were looking for a 1.0 log reduction in HBsAG from this ARC-520 study, although the company and sell-side analysts were framing a win with a 0.5 to 1.0 log reduction. If ARC-520 accomplished an 0.8 log reduction, as today's announcement suggests, it will likely be viewed positively.
HBsAG levels continue to decline in during the study and Arrowhead says the drug appears safe enough to dose another cohort of hepatitis B patients with a higher 3 mg dose of ARC-520. On its call, Arrowhead expressed confidence in achieving a 1 log reduction in HBsAG with the 3 mg dose.
This is GOOD news/
. Buy any dip.
A lot of companies profit from a stock price jump by issuing secondary shares.
It's been a long time since MDVN has been over $79. Let's hope management let's us enjoy it for a while.
Despite record number of Americans (92+ million) who are no longer in the labor force,. rapidly declining entrepreneurship with more companies closing than opening across America and a record-breaking poverty rate (50 million Americans now live below the poverty line), Reuters still manages to blame former President Bush (not by name, but indirectly by reference to the “Great Recession”) and give Obama a free pass on all his economically disastrous, anti-growth, and anti-wealth-creation policies he implements and continues to champion.
A quarter of U.S. families feel they are under economic stress due to the aftershock of the Great Recession and most do not expect their wages to increase in the next year, according to a new Federal Reserve study released on Thursday.
No, Reuters, many American families are not still under economic duress "from the aftershocks of the great recession" that ended 5 years ago. American families are under duress and face increasing poverty due to the anti-business, anti-growth, anti-entrepreneurship, anti-freedom, high taxes, and oppressive regulations and policies that the Obama administration has been shoving down our throats since 2009.
Despite the dire economic conditions and negative effects on middle-class families their misguided economic policies have precipitated, President Obama and the Democrats still want more tax increases, increased anti-growth government regulations, and more punitive restrictions on business activities. All the while they insanely cheerlead the increase of illegal immigration and championing the main cause of wage deflation and stagnation: “the importation of endless numbers of new cheap foreign workers across all industries.” There is nothing coming out of this White House that would signal to American businesses and workers that it is willing to change course and let the private sector do its job properly.
Save the insult. You're on "ignore"
American Airlines AAL has a PEG of 0.15.
Giliad's problem is that nobody believes they can keep making that much from Sovaldi.
1) Insurance companies rebel and refuse to cover Sovaldi.
2) Government intervenes and strong arms Giliad with regulatory attacks, IRS audits, SEC investigations, etc
3) Another drug company gets expedited approval for a similar drug at a much lower price.
The homeownership rate in the U.S. fell to a 19-year low as rising prices and tight credit kept many first-time buyers out of the property market.
The share of Americans who own their homes was 64.7 percent in the second quarter, down from 64.8 percent in the previous three months, the Census Bureau said in a report today. The rate matched the level in the second quarter of 1995. Housing has become less affordable and more difficult to finance for entry-level buyers, even as mortgage rates have held close to record lows. First-time purchasers accounted for 28 percent of all sales of previously owned homes in June, compared with about 40 percent historically, according to the National Association of Realtors.
If the real estate sector pulls back, the value of AGNC's MBS portfolio will decline and if the Fed raises rates dividend paying stocks will decline. Today's pullback could also be "sell the news" by people who anticipated a bigger pop on earnings.
8:05 am Jazz Pharma: CANbridge Life Sciences And EUSA Pharma form agreement to commericalize caphosol in China (JAZZ) :
•CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, has entered into an exclusive partnership with EUSA Pharma, a Jazz Pharmaceuticals company (JAZZ), to commercialize Caphosol in China.
•Under the terms of the agreement, CANbridge obtains exclusive rights to commercialize Caphosol in China, where over 3.5 million new cancer cases are diagnosed each year, and there is little in the way of a standard adjunct therapy to treat oral mucositis.
Seems like good news but JAZZ sold off!
It already has, but people who decided that was a great time to short the stock have gotten their heads handed to them in a short squeeze.
Why not blame lawyers and politicians? The average doctor pays a quarter-million a year in malpractice insurance. Regulations associated with Obamacare are so extensive and so confusing that each doctor is forced to hire several admin assistants to handle the paperwork.
Lawyers don't have to pay anything before they go out and start suing people. Why don't we charge lawyers a million dollars a year to practice law?